This study is looking at a behavioral therapy called Acceptance and Commitment Therapy (ACT for SCD) for Black adolescents and young adults (ages 14-21) who have sickle cell disease. The goal is to see if this 6-session group therapy can help with stress related to race and chronic illness, and if it's something people find helpful and easy to participate in. Researchers will measure changes in race-related stress after 12 weeks, and self-efficacy (your belief in your ability to succeed) and internalized stigma (negative feelings about your condition) after 6 months. The study is currently unclear on its recruitment status and plans to enroll 66 participants.

Study design

This is an interventional study, meaning participants will receive a specific therapy. It involves a small group of 30 participants in a non-randomized way, with 8-10 people in each group.

What's involved

Participants will enroll in a 6-session ACT group. The study will measure outcomes at 12 weeks and 6 months.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 6 months after starting the intervention to measure certain outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.